cancer du sein; femme jeune; caractéristiques clinico-pathologiques; prise en charge spécifique; oncologie; breast cancer; young women; biopathological parameters; specific management; oncology
Disciplines :
Oncology
Author, co-author :
ANDRE, Chantal ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
COLLIGNON, Joëlle ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
RORIVE, Andrée ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
MARTIN, Marie
MAWEJA, Sylvie ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation
LIFRANGE, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
COUCKE, Philippe ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale
Pollan M. - Epidemiology of breast cancer in young women. Breast Cancer Res Treat, 2010, 123, 3-6.
Bouchardy C, Fioretta G, Verkooijen HM, et al. - Recent increase of breast cancer incidence among women under the age of forty. Br J Cancer, 2007, 96, 1743-1746. (Pubitemid 46847205)
Molinié F, Daubisse-Marliac Epidémiologie du cancer du sein de la femme jeune : 32ème journée de la Société française de Sénologie et de Pathologie mammaire, 2010.
Cancello G, Maisonneuve P, Rotmensz N, et al. - Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol, 2010, 21, 1974-1981.
Silver DP, Richardson AL, Eklund AC, et al. - Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol, 2010, 28, 1145-1153.
Ashworth A. - A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J Clin Oncol, 2008, 26, 3785-3790.
Voduc KD, Cheang MC, Tyldesley S, et al. - Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 2010, 28, 1684-1691.
Katz SJ, Lantz PM, Janz NK, et al. - Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol, 2005, 23, 5526-5533.
Coucke PA, Vavassis P, Vanderick J. - Tumor margin after conservative breast cancer surgery for early disease : an issue or not? BJMO, 2009, 3, 93-100.
Chang HR. - Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer. Cancer, 2010, 116, 2856-2867.
Sardanelli F, Boetes C, Borisch B, et al. - Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer, 2010, 46, 1296-1316.
Bonilla L, Ben-Aharon I, Vidal L, et al. - Dose-dense chemotherapy in nonmetastatic breast cancer : a systematic review and meta-analysis of randomized controlled trials. J Natl Cancer Inst, 2010, 102, 1845-1854.
Romond EH, Perez EA, Bryant J, et al. - Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med, 2005, 353, 1673-1684. (Pubitemid 41464706)
Chang HR, Slamon D, Prati R. - A phase II study of neoadjuvant docetaxel/carboplatin with or without trastuzumab in locally advanced breast cancer : response and cardiotoxicity. J Clin Oncol, 2006, 24, abstract10515.
Ismail-Khan R, Minton S, Cox C, et al. - Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer, 2008, 26, abstract 524.
Azim HA Jr, Azambuja E, Colozza M, et al. - Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol, 2011, Feb 2. Epub ahead of print.